Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

589 ARTÍCULOS , VIENDO DEL 151 AL 165

Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders

Agnihotri TG, Jadhav GS, Sahu B, Jain A.

Drug Deliv Transl Res. 2022 Dec;12(12):3104-3120. doi: 10.1007/s13346-022-01173-y. Epub 2022 May 15.

Brexpiprazole-Associated Pisa Syndrome (Pleurothotonus) in a Patient With Dementia

Nagai Y, Yamazaki T, Sugita T, Shibata N.

Clin Neuropharmacol. 2022 May-Jun 01;45(3):72-73. doi: 10.1097/WNF.0000000000000500. Epub 2022 Apr 14.

The amyloid precursor protein: a converging point in Alzheimer's disease

Delport A, Hewer R.

Mol Neurobiol. 2022 Jul;59(7):4501-4516. doi: 10.1007/s12035-022-02863-x. Epub 2022 May 17.

Are mitophagy enhancers therapeutic targets for Alzheimer's disease?

Pradeepkiran JA, Hindle A, Kshirsagar S, Reddy PH.

Biomed Pharmacother. 2022 May;149:112918. doi: 10.1016/j.biopha.2022.112918. Epub 2022 Apr 4.

Amyloid-beta Targeted Therapeutic Approaches for Alzheimer's Disease: Long Road Ahead

Dai Y, Lei C, Zhang Z, Qi Y, Lao K, Gou X.

Curr Drug Targets. 2022;23(11):1040-1056. doi: 10.2174/1389450123666220421124030.

Targeting Necroptosis as a Promising Therapy for Alzheimer's Disease

Zhao W, Liu Y, Xu L, He Y, Cai Z, Yu J, Zhang W, Xing C, Zhuang C, Qu Z.

ACS Chem Neurosci. 2022 Jun 15;13(12):1697-1713. doi: 10.1021/acschemneuro.2c00172. Epub 2022 May 23.

Latest progress in the development of multitarget ligands for Alzheimer's disease based on the Hantzsch reaction

Ismaili L, Bernard PJ, Refouvelet B.

Future Med Chem. 2022 Jul;14(13):943-946. doi: 10.4155/fmc-2022-0080. Epub 2022 May 24.

Role of Aducanumab in the Treatment of Alzheimer's Disease: Challenges and Opportunities

Vaz M, Silva V, Monteiro C, Silvestre S.

Clin Interv Aging. 2022 May 18;17:797-810. doi: 10.2147/CIA.S325026. eCollection 2022.

Determination of Anti-Alzheimer's Disease Activity of Selected Plant Ingredients

Tuzimski T, Petruczynik A.

Molecules. 2022 May 18;27(10):3222. doi: 10.3390/molecules27103222.

A tough trek in the development of an anti-amyloid therapy for Alzheimer's disease: Do we see hope in the distance?

Luo JJ, Wallace W, Kusiak JW.

J Neurol Sci. 2022 Jul 15;438:120294. doi: 10.1016/j.jns.2022.120294. Epub 2022 May 23.

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress

Sang Z, Wang K, Dong J, Tang L.

Eur J Med Chem. 2022 Aug 5;238:114464. doi: 10.1016/j.ejmech.2022.114464. Epub 2022 May 20.

Impact of New Drugs for Therapeutic Intervention in Alzheimer's Disease

Olloquequi J, Ettcheto M, Cano A, Sanchez-López E, Carrasco M, Espinosa T, Beas-Zarate C, Gudiño-Cabrera G, Ureña-Guerrero ME, Verdaguer E, Folch J, Auladell C, Camins A.

Front Biosci (Landmark Ed). 2022 May 6;27(5):146. doi: 10.31083/j.fbl2705146.

Abdominal fullness and discomfort induced by an extract of the Japanese herbal medicine Tsumura Ninjin'yoeito: The cases of two patients with Alzheimer's disease and anorexia

Sato S, Tamura M, Ide M, Matsuzaki A, Shiratori Y, Hisanaga A.

Psychiatry Clin Neurosci. 2022 Aug;76(8):406-407. doi: 10.1111/pcn.13431. Epub 2022 Jun 23.

Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients

Vissers MFJM, Heuberger JAAC, Groeneveld GJ, Oude Nijhuis J, De Deyn PP, Hadi S, Harris J, Tsai RM, Cruz-Herranz A, Huang F, Tong V, Erickson R, Zhu Y, Scearce-Levie K, Hsiao-Nakamoto J, Tang X, Chang M, Fox BM, Estrada AA, Pomponio RJ, Alonso-Alonso M, Zilberstein M, Atassi N, Troyer MD, Ho C.

Clin Transl Sci. 2022 Aug;15(8):2010-2023. doi: 10.1111/cts.13317. Epub 2022 Jun 1.

The Potential of Genetic Data for Prioritizing Drug Repurposing Efforts

Gill D, Vujkovic M.

Neurology. 2022 Aug 16;99(7):267-268. doi: 10.1212/WNL.0000000000200803. Epub 2022 Jun 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias